← FDA DRUG APPROVALS

FDA ANDA · ANDA202411

MAGNESIUM SULFATE

Sponsor: HOSPIRA

APPLICATION
ANDA202411
TYPE
ANDA
ORIGINAL APPROVAL
2015-05-14
LATEST ACTION
2019-03-11
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INTRAMUSCULAR, INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

MAGNESIUM SULFATEPrescription
MAGNESIUM SULFATE 10GM/20ML (500MG/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS

Approval history

2019-03-11Manufacturing (CMC) · Supplement 2 · unknownAP
2015-05-14UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →